Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hypertension is the most important risk factor for cardiovascular and cerebrovascular diseases，and also a substantial public health problem. The purpose of the study is to investigate the association between plasma biomarkers and adverse outcomes in patients with hypertension.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Primary mortality of hypertension | The incidence rate of primary mortality of hypertension | Through study completion, an average of 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Secondary outcomes of heart | The incidence rate of left ventricular hypertrophy, myocardial infarction, congestive heart failure, and arrhythmia | Through study completion, an average of 2 years |
| Secondary outcomes of brain |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Pregnancy, history of heart failure or left ventricular ejection fraction less than 40%, myocardial infarction within one month, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting, cerebrovascular disease, severe liver disease, severe chronic renal failure (eGFR less than 30 mL/min/1.73 m2) in the past three months.
Not provided
Not provided
Not provided
Hospitalized patients with hypertension
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yulin Li, PhD | Contact | 0086-010-64456453 | lyllyl_1111@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Jie Du, PhD | Beijing Anzhen Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Anzhen Hospital | Recruiting | Beijing | Beijing Municipality | 100029 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
The incidence rate of stroke (include cerebral hemorrhage and cerebral ischemia
| Through study completion, an average of 2 years |
| Secondary outcomes of kidney | The incidence rate of hypertensive renal injure and end-stage renal disease | Through study completion, an average of 2 years |
| Secondary outcomes of eyes | The incidence rate of hypertensive eye injure | Through study completion, an average of 2 years |